Anti-CYP1A2 monoclonal antibody

Pre-made anti-CYP1A2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CYP1A2/CYP1A2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0643-Ab-1/ GM-Tg-hg-IP0643-Ab-2Anti-Human CYP1A2 monoclonal antibodyHuman
GM-Tg-rg-IP0643-Ab-1/ GM-Tg-rg-IP0643-Ab-2Anti-Rat CYP1A2 monoclonal antibodyRat
GM-Tg-mg-IP0643-Ab-1/ GM-Tg-mg-IP0643-Ab-2Anti-Mouse CYP1A2 monoclonal antibodyMouse
GM-Tg-cynog-IP0643-Ab-1/ GM-Tg-cynog-IP0643-Ab-2Anti-Cynomolgus/ Rhesus macaque CYP1A2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0643-Ab-1/ GM-Tg-felg-IP0643-Ab-2Anti-Feline CYP1A2 monoclonal antibodyFeline
GM-Tg-cang-IP0643-Ab-1/ GM-Tg-cang-IP0643-Ab-2Anti-Canine CYP1A2 monoclonal antibodyCanine
GM-Tg-bovg-IP0643-Ab-1/ GM-Tg-bovg-IP0643-Ab-2Anti-Bovine CYP1A2 monoclonal antibodyBovine
GM-Tg-equg-IP0643-Ab-1/ GM-Tg-equg-IP0643-Ab-2Anti-Equine CYP1A2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0643-Ab-1/ GM-Tg-hg-IP0643-Ab-2; GM-Tg-rg-IP0643-Ab-1/ GM-Tg-rg-IP0643-Ab-2;
GM-Tg-mg-IP0643-Ab-1/ GM-Tg-mg-IP0643-Ab-2; GM-Tg-cynog-IP0643-Ab-1/ GM-Tg-cynog-IP0643-Ab-2;
GM-Tg-felg-IP0643-Ab-1/ GM-Tg-felg-IP0643-Ab-2; GM-Tg-cang-IP0643-Ab-1/ GM-Tg-cang-IP0643-Ab-2;
GM-Tg-bovg-IP0643-Ab-1/ GM-Tg-bovg-IP0643-Ab-2; GM-Tg-equg-IP0643-Ab-1/ GM-Tg-equg-IP0643-Ab-2
Products NameAnti-CYP1A2 monoclonal antibody
Formatmab
Target NameCYP1A2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CYP1A2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0643-Ag-1Recombinant multi-species CP1A2/ CYP1A2/ CP12 protein
    ORF Viral VectorpGMLPm002709mouse Cyp1a2 Lentivirus plasmid
    ORF Viral VectorvGMLPm002709mouse Cyp1a2 Lentivirus particle


    Target information

    Target IDGM-IP0643
    Target NameCYP1A2
    Gene ID1544,554345,503552,100062244
    Gene Symbol and SynonymsCP12,CYP1A2,CYPIA2,P3-450,P450(PA)
    Uniprot AccessionP05177,Q5KQT6
    Uniprot Entry NameCP1A2_HUMAN,CP1A2_FELCA
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000140505
    Target ClassificationTumor-associated antigen (TAA)

    The target: CYP1A2, gene name: CYP1A2, also named as CP12, CYPIA2, P3-450, P450(PA). This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown; however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.